A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc (Q35977461)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc |
scientific article |
Statements
1 reference
A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc (English)
1 reference
Bleehen NM
1 reference
Girling DJ
1 reference
Machin D
1 reference
Stephens RJ
1 reference
1 December 1993
1 reference
1 reference
1150-1156
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference